Apiam Animal Health Limited (ASX:AHX) FY22 Reporting Date and Investor Webinar Notification
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the twelve months ended 30 June 2022 on Monday August 29 2022.
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the twelve months ended 30 June 2022 on Monday August 29 2022.
Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has extended its Cooperation Agreement with Codi International BV, part of the Codi Group ("Codi"), for a further three years.
Within racing circles, Bendigo Racecourse is commonly referred to as the Nursery of Champions due to the amount of legends that have started their careers at the famous track now named Apiam Bendigo racecourse.
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 30 June 2022.
Nanollose Limited (ASX:NC6) (FRA:N0L) a leading biomaterials company, focused on commercialising scalable technology to create fibres and fabrics with minimal environmental impact, is pleased to provide shareholders with an overview of its activities for the period ended 30 June 2022.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has commenced recruitment of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic SteatoHepatitis.
Apiam Animal Health Limited (ASX:AHX) today announces that it has completed settlement of the Victorian Equine Group and The Vet Practice Pty Ltd effective as at 1 July 2022.